Cite
MLA Citation
Christian Goess et al.. “ABBV-105, a selective and irreversible inhibitor of Bruton's tyrosine kinase, is efficacious in multiple preclinical models of inflammation.” Modern rheumatology, vol. 29, no. 3, 2019, pp. 510–522. http://access.bl.uk/ark:/81055/vdc_100081440679.0x00003b